Groundbreaking Research from Singapore Boosts Hair Resilience and Reduces Scalp Redness
In a significant advancement for the hair care industry, Singapore's CellResearch Corporation has unveiled compelling new findings regarding its proprietary active ingredient, PTT-6®. Presented at the prestigious Aesthetic and Anti-Aging Medicine World Congress (AMWC) in Japan, these results challenge conventional wisdom regarding hair and scalp care, promising remarkable improvements in hair resilience and scalp health.
The studies focused on two key performance indicators: hair breakage resistance and scalp redness. Independent laboratory testing revealed that hair treated with PTT-6® demonstrated a 43% increase in breaking work compared to untreated counterparts, underscoring its ability to enhance structural strength significantly. This improvement in hair fibers is vital for individuals undergoing frequent chemical treatments such as bleaching or perming, which typically weaken hair over time.
Dr. Ivor Lim, Group Chief Medical Officer of CellResearch Corporation, emphasized the importance of these findings, noting how they present measurable evidence in a market increasingly mindful of clinical validation. He stated, "Hair breakage is a cumulative issue, impacted by daily routines as well as chemical stressors. By raising the threshold for resilience, our product could significantly reduce the risk of breakage."
Furthermore, the study addressing scalp condition reported a 14% reduction in scalp redness over a 28-day period of using the PTT-6® Scalp Activating Mist. These findings were corroborated by subjective feedback from participants, all of whom confirmed a reduction in irritation. In addition to providing immediate benefits, the continuous use of PTT-6® resulted in a marked 22% decrease in water loss from the scalp, indicating improved hydration and lower sensitivity, thus creating a healthier environment for hair growth.
The dual benefits of PTT-6® position it as a unique solution in the burgeoning hair care market, which is anticipated to grow from USD 93.6 billion in 2026 to USD 150.5 billion by 2033. Dr. Mikiko Hiraoka, a dermatologist and founder of Tokyo’s Ginza Richesse Clinic, also touched on how soothing scalp conditions is essential for any effective hair treatment regimen, remarking, "The combination of a calming scalp, increased hair growth, and stronger strands makes this a groundbreaking integrated approach."
With over two decades of substantial research backing its applications, CellResearch Corporation is set to expand its brand, CALECIM® Professional, further into international markets while continuing to innovate in scalp and hair treatments. As the demand for effective, clinically validated hair care products rises, the insights shared at AMWC Japan are likely to spark a new direction in formulations across the industry.
As described in multiple trials administered across six countries, including the USA and Australia, PTT-6® not only promotes the health of existing hair but also aids in the regrowth process, finding a place in the routines of consumers and professionals alike. This research represents not merely an academic exercise but a roadmap for the future of hair and scalp care, aligning consumer needs with scientific advancements for better overall results.
In the face of a marketplace dominated by superficial marketing claims, CellResearch Corporation’s evidence-based approach stands out. The findings advocate for a shift in how consumers perceive hair and scalp care products, suggesting that true efficacy is increasingly determined by scientific query rather than anecdotal evidence or persuasive advertising.
To conclude, these groundbreaking results herald a new chapter in hair care, one that is founded on the principles of scientific rigor and clinical validation. As the industry stands on the cusp of significant transformation, the role of companies like CellResearch Corporation will be central to shaping its future trajectory.
The studies focused on two key performance indicators: hair breakage resistance and scalp redness. Independent laboratory testing revealed that hair treated with PTT-6® demonstrated a 43% increase in breaking work compared to untreated counterparts, underscoring its ability to enhance structural strength significantly. This improvement in hair fibers is vital for individuals undergoing frequent chemical treatments such as bleaching or perming, which typically weaken hair over time.
Dr. Ivor Lim, Group Chief Medical Officer of CellResearch Corporation, emphasized the importance of these findings, noting how they present measurable evidence in a market increasingly mindful of clinical validation. He stated, "Hair breakage is a cumulative issue, impacted by daily routines as well as chemical stressors. By raising the threshold for resilience, our product could significantly reduce the risk of breakage."
Furthermore, the study addressing scalp condition reported a 14% reduction in scalp redness over a 28-day period of using the PTT-6® Scalp Activating Mist. These findings were corroborated by subjective feedback from participants, all of whom confirmed a reduction in irritation. In addition to providing immediate benefits, the continuous use of PTT-6® resulted in a marked 22% decrease in water loss from the scalp, indicating improved hydration and lower sensitivity, thus creating a healthier environment for hair growth.
The dual benefits of PTT-6® position it as a unique solution in the burgeoning hair care market, which is anticipated to grow from USD 93.6 billion in 2026 to USD 150.5 billion by 2033. Dr. Mikiko Hiraoka, a dermatologist and founder of Tokyo’s Ginza Richesse Clinic, also touched on how soothing scalp conditions is essential for any effective hair treatment regimen, remarking, "The combination of a calming scalp, increased hair growth, and stronger strands makes this a groundbreaking integrated approach."
With over two decades of substantial research backing its applications, CellResearch Corporation is set to expand its brand, CALECIM® Professional, further into international markets while continuing to innovate in scalp and hair treatments. As the demand for effective, clinically validated hair care products rises, the insights shared at AMWC Japan are likely to spark a new direction in formulations across the industry.
As described in multiple trials administered across six countries, including the USA and Australia, PTT-6® not only promotes the health of existing hair but also aids in the regrowth process, finding a place in the routines of consumers and professionals alike. This research represents not merely an academic exercise but a roadmap for the future of hair and scalp care, aligning consumer needs with scientific advancements for better overall results.
In the face of a marketplace dominated by superficial marketing claims, CellResearch Corporation’s evidence-based approach stands out. The findings advocate for a shift in how consumers perceive hair and scalp care products, suggesting that true efficacy is increasingly determined by scientific query rather than anecdotal evidence or persuasive advertising.
To conclude, these groundbreaking results herald a new chapter in hair care, one that is founded on the principles of scientific rigor and clinical validation. As the industry stands on the cusp of significant transformation, the role of companies like CellResearch Corporation will be central to shaping its future trajectory.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.